The medicines you are using mixed with Water for injections may interact with each other.

Similar documents
Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

Hartmann s Solution. For Infusion

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Voluven 10 % solution for infusion Hydroxyethyl starch (HES 130/0.4) in isotonic sodium chloride solution

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

Package leaflet: Information for the patient. Paracetamol 10 mg/ml solution for infusion. Paracetamol

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Package leaflet: Information for the user. Chirocaine mg/ml or 1.25 mg/ml solution for infusion For epidural use only.

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

Package leaflet: Information for the user. Chirocaine 2.5 mg/ml and 5.0 mg/ml solution for injection/concentrate for solution for infusion

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

Package Leaflet: Information for user

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Package leaflet: Information for the patient

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

Package Leaflet: Information for the user

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package leaflet: Information for the user. Poliomyelitis Vaccine (Inactivated) suspension for injection in pre-filled syringe

Suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

Package leaflet: Information for the user Venofer 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose

Package Leaflet: Information for the user. Digestisan oral drops

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package leaflet: Information for the user

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package leaflet: Information for the user. {Product name} 100 mg/100 mg/1 mg/20 mg/2 ml solution for injection

1. What Octostim Nasal Spray is and what it is used for

1. What Faslodex is and what it is used for

Benylin Phlegm Cough Menthol 100mg/5ml Oral Solution Guaifenesin

Package leaflet: Information for the user. ReoPro 2 mg/ml solution for injection or infusion. abciximab

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

PACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin

PACKAGE LEAFLET: INFORMATION FOR THE USER

2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. AVAXIM, Suspension for injection in a pre-filled syringe Hepatitis A vaccine (inactivated, adsorbed)

Package leaflet: Information for the user. Naloxone 400 microgram/ml solution for injection or infusion naloxone hydrochloride

ANDROGEL 50 mg, gel in sachet Testosterone

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the user. Tuberculin PPD RT23 "SSI" 2 T.U./0.1 ml, solution for injection Tuberculin PPD RT 23

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the user. Methylthioninium chloride Proveblue 5 mg/ml solution for injection Methylthioninium chloride

ANBESOL TM Anaesthetic Antiseptic Oromucosal solution Lidocaine hydrochloride 0.90%w/w, Chlorocresol 0.10%w/w, Cetylpyridinium Chloride 0.

Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride

Package leaflet: Information for the user. Cyanokit 5 g powder for solution for infusion hydroxocobalamin

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Kabiven, emulsion for infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Sodium Chloride 0.9% w/v Intravenous Infusion BP

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

1. What Miacalcic is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Technescan MIBI 1 mg, kit for radiopharmaceutical preparation

Package leaflet: Information for the user. Salofalk 3g gastro-resistant prolonged-release granules. Mesalazine

Package leaflet: Information for the user. HBVAXPRO 5 micrograms, suspension for injection in pre-filled syringe Hepatitis B vaccine (rdna)

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

Package leaflet: Information for the user. (Insulin human)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Budesonide Teva 0.5 mg/2 ml Nebuliser Suspension Budesonide

Package leaflet: Information for the patient

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the user Priorix, powder and solvent for solution for injection in a pre-filled syringe

Package leaflet: Information for the user. Paralink 10 mg/ml Solution for Infusion Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Avodart 0.5 mg soft capsules dutasteride

Package leaflet: Information for the user. (Insulin human)

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER solvent for parenteral use Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.. What is in this leaflet 4. Possible side effects Water for Injections is pure, sterile water. It is used to dilute medicines before use. For example medicines that are given by: - injection (given using a needle, for example into your vein) - infusion (slow injection) into a vein, also called a drip. Do not use : You must NOT receive on its own. If injected into your bloodstream on its own it can cause your red blood cells to take in water and burst (haemolysis). This is because does not have the same consistency as your blood. will always be mixed with one or more medicines by a healthcare professional before you receive it. You should read the Patient Information Leaflet of your medicine or medicines that are being mixed with. These will tell you whether or not you can receive the solution. Warnings and precautions Talk to your doctor or pharmacist before using. should not be used on its own. Before you use : - it will always be mixed with one or more medicines - your healthcare professional will make sure that the mixture is roughly the same consistency as your blood (isotonic). Depending on the type of medicine you are given, this will mean that: - the medicine needs to be diluted with - another substance needs to be added to your mixture of Water for injections and medicine before use. You will be more likely to suffer haemolysis if you are given large volumes of hypotonic solutions of (solutions that are not as concentrated as your blood). To help preventing this, your doctor will take a blood sample to monitor the balance of the chemicals in your blood (the ionic balance). Before you are given medicines mixed with your doctor will check that: - the medicines are stable in - the medicines will not interact with each other Other medicines and Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. V001/VS (BP8) The medicines you are using mixed with may interact with each other. with food and drink You should ask your doctor about what you can eat or drink. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Any risk to your unborn baby or your pregnancy will depend on Any risk to your baby during breast-feeding will also depend on Your doctor will be able to advise you on what risks are involved in taking particular medicines. Your doctor will only give you medicines during pregnancy or breast-feeding if it is essential. Driving and using machines does not affect your ability to drive or use machines. Any effects on your ability to drive or use machines will depend on Your doctor will be able to advise you on this. Water for Injections will be given to you by a doctor or nurse. Your doctor will decide on how much you need and when and how it is to be given. This will depend on which medicine or medicines you need to take with Water for Injections. Your doctor will also consider your age, weight, condition and what other treatments you are receiving. You should NOT be given Water for Injections if there are particles floating in the water or if the pack is damaged in any way. Handling instructions: To break off a single ampoule, twist one ampoule against the remaining ampoules of the pack without touching the head and neck of the ampoules (1). Shake the ampoule with one single movement as shown below in order to remove the liquid kept in the cap (2). To open the ampoule, twist the ampoule body and the ampoule head in opposite directions until the neck breaks off (3). Connect the ampoule to the luer-syringe or luer-lock syringe as shown in figure (4). 1 2 3 4 Therefore, no needle is needed to extract the solution. Extract the liquid. If you receive more than you should: if you are given too much Water for Injections (over-infusion) this may lead to haemolysis. Haemolysis is when your red blood cells take in water and burst. The medicines mixed with Water for Injections may also cause symptoms if administered in too large quantities (over-infusion). Any signs and symptoms of overdose will depend on which medicines you are using mixed with Water for Injections. If you are accidentally given an overdose your treatment will be stopped and you will be given treatment depending on the symptoms. You should read the Patient Information Leaflet of the medicines mixed with Water for Injections for a list of possible symptoms of over-infusion. If you have any further questions on the use of this product, ask your doctor.

4. Possible side effects Like all medicines, can cause side effects, although not everybody gets them. You may suffer bursting (haemolysis) of your red blood cells if: - you use Water for Injections on its own - Water for Injections is used to make solutions for injection or infusion that are not of a similar consistency to your blood (isotonic). If a medicine has been added to Water for Injections, the added medicine may also cause side effects. These side effects will depend on the medicine that has been added. You should read the Patient Information Leaflet of the added medicine for a list of possible symptoms. If you notice any side effects or are concerned about anything, please tell your doctor or nurse. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine. For Ireland HPRA Pharmacovigilance Earlsfort Terrace IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie e-mail: medsafety@hpra.ie. Keep this medicine out of the sight and reach of children. This medicine does not require any special storage conditions. Keep the ampoule in the outer carton. Do not use this medicine after the expiry date which is stated on the label/carton after EXP. The expiry date refers to the last day of that month. Once the pack is opened should be used straight away. Manufacturer: FRESENIUS KABI ESPAÑA, S.A. C/ Marina, 16-18, planta 17 08005-Barcelona (SPAIN) This medicinal product is authorised in the Member States of the EEA under the following names: Belgium Water voor injecties Fresenius Kabi Czech Republic Water for Injection Kabi Estonia Greece Water For Injection Kabi, Διαλύτης για ενέσιμα μικρού όγκου (<50ml). Hungary Injekcióhoz való víz Kabi Ireland solvent for parenteral use Latvia Lithuania The Netherlands Water voor injecties Fresenius Kabi Poland Aqua pro iniectione Kabi Romania Apă pentru preparate injectabile Kabi, solvent pentru uz parenteral Slovakia Water for Injection Kabi Slovenia Voda za injekcije Fresenius Kabi vehikel za parenteralno uporabo Spain Agua para inyección Meinsol, disolvente para uso parenteral This leaflet was last approved in 03/2015 The following information is intended for medical or healthcare professionals only: Handling and Preparation Use only if the solution is clear, without visible particles and if the container is undamaged. Water for Injections should not be infused alone. The infusion should be made isotonic prior to parenteral administration. Solutions containing additives should be used immediately and not stored. Discard after single use. Discard any unused portion. What contains The only active ingredient is sterile water for injections. Each presentation contains 100% sterile water for injections. What looks like and contents of the pack is a clear solution, free from visible particles and it is presented as the following formats: Package with 20 ampoules containing 5 ml Package with 50 ampoules containing 5 ml Package with 20 ampoules containing 10 ml Package with 50 ampoules containing 10 ml Package with 20 ampoules containing 20 ml Package with 1 bottle containing 500 ml Package with 10 bottles containing 500 ml Package with 1 bottle containing 1000 ml Package with 10 bottles containing 1000 ml Not all pack sizes may be marketed Marketing Authorisation Holder and Manufacturer: Marketing Authorisation Holder Fresenius Kabi Limited, Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT United Kingdom V001/VS (BP8) In-use shelf-life: Additives Chemical and physical stability of any additive at the ph of Water for Injections (4.5 to 7.0) in the container should be established prior to use. From a microbiological point of view, the diluted product should be used immediately, unless reconstitution has taken place in controlled and validated aseptic conditions. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user. Incompatibilities of additive medications As with all parenteral solutions, before adding medications, compatibility of these additives with the solution must be assessed. The Instructions for Use of the medicinal product to be added must be consulted. Before adding a medicinal product, verify it is soluble and stable in water at the ph of Water for Injections (4.5 to 7.0)

(Irlanda) BP8 Colour: Black Size: 148 x 210 mm Fonts size: 12/6,5 pt 13.5.2015 Correction: 2 Version: 00

PACKAGE LEAFLET: INFORMATION FOR THE USER solvent for parenteral use Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.. What is in this leaflet 4. Possible side effects Water for Injections is pure, sterile water. It is used to dilute medicines before use. For example medicines that are given by: - injection (given using a needle, for example into your vein) - infusion (slow injection) into a vein, also called a drip. Do not use : You must NOT receive on its own. If injected into your bloodstream on its own it can cause your red blood cells to take in water and burst (haemolysis). This is because does not have the same consistency as your blood. will always be mixed with one or more medicines by a healthcare professional before you receive it. You should read the Patient Information Leaflet of your medicine or medicines that are being mixed with. These will tell you whether or not you can receive the solution. Warnings and precautions Talk to your doctor or pharmacist before using. should not be used on its own. Before you use : - it will always be mixed with one or more medicines - your healthcare professional will make sure that the mixture is roughly the same consistency as your blood (isotonic). Depending on the type of medicine you are given, this will mean that: - the medicine needs to be diluted with - another substance needs to be added to your mixture of Water for injections and medicine before use. You will be more likely to suffer haemolysis if you are given large volumes of hypotonic solutions of (solutions that are not as concentrated as your blood). To help preventing this, your doctor will take a blood sample to monitor the balance of the chemicals in your blood (the ionic balance). Before you are given medicines mixed with your doctor will check that: - the medicines are stable in - the medicines will not interact with each other Other medicines and Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. V001/VS (BP9) The medicines you are using mixed with may interact with each other. with food and drink You should ask your doctor about what you can eat or drink. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Any risk to your unborn baby or your pregnancy will depend on Any risk to your baby during breast-feeding will also depend on Your doctor will be able to advise you on what risks are involved in taking particular medicines. Your doctor will only give you medicines during pregnancy or breast-feeding if it is essential. Driving and using machines does not affect your ability to drive or use machines. Any effects on your ability to drive or use machines will depend on Your doctor will be able to advise you on this. Water for Injections will be given to you by a doctor or nurse. Your doctor will decide on how much you need and when and how it is to be given. This will depend on which medicine or medicines you need to take with Water for Injections. Your doctor will also consider your age, weight, condition and what other treatments you are receiving. You should NOT be given Water for Injections if there are particles floating in the water or if the pack is damaged in any way. Handling instructions: To break off a single ampoule, twist one ampoule against the remaining ampoules of the pack without touching the head and neck of the ampoules (1). Shake the ampoule with one single movement as shown below in order to remove the liquid kept in the cap (2). To open the ampoule, twist the ampoule body and the ampoule head in opposite directions until the neck breaks off (3). Connect the ampoule to the luer-syringe or luer-lock syringe as shown in figure (4). 1 2 3 4 Therefore, no needle is needed to extract the solution. Extract the liquid. If you receive more than you should: if you are given too much Water for Injections (over-infusion) this may lead to haemolysis. Haemolysis is when your red blood cells take in water and burst. The medicines mixed with Water for Injections may also cause symptoms if administered in too large quantities (over-infusion). Any signs and symptoms of overdose will depend on which medicines you are using mixed with Water for Injections. If you are accidentally given an overdose your treatment will be stopped and you will be given treatment depending on the symptoms. You should read the Patient Information Leaflet of the medicines mixed with Water for Injections for a list of possible symptoms of over-infusion. If you have any further questions on the use of this product, ask your doctor.

4. Possible side effects Like all medicines, can cause side effects, although not everybody gets them. You may suffer bursting (haemolysis) of your red blood cells if: - you use Water for Injections on its own - Water for Injections is used to make solutions for injection or infusion that are not of a similar consistency to your blood (isotonic). If a medicine has been added to Water for Injections, the added medicine may also cause side effects. These side effects will depend on the medicine that has been added. You should read the Patient Information Leaflet of the added medicine for a list of possible symptoms. If you notice any side effects or are concerned about anything, please tell your doctor or nurse. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine. For Ireland HPRA Pharmacovigilance Earlsfort Terrace IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie e-mail: medsafety@hpra.ie. Keep this medicine out of the sight and reach of children. This medicine does not require any special storage conditions. Keep the ampoule in the outer carton. Do not use this medicine after the expiry date which is stated on the label/carton after EXP. The expiry date refers to the last day of that month. Once the pack is opened should be used straight away. Manufacturer: FRESENIUS KABI ESPAÑA, S.A. C/ Marina, 16-18, planta 17 08005-Barcelona (SPAIN) This medicinal product is authorised in the Member States of the EEA under the following names: Belgium Water voor injecties Fresenius Kabi Czech Republic Water for Injection Kabi Estonia Greece Water For Injection Kabi, Διαλύτης για ενέσιμα μικρού όγκου (<50ml). Hungary Injekcióhoz való víz Kabi Ireland solvent for parenteral use Latvia Lithuania The Netherlands Water voor injecties Fresenius Kabi Poland Aqua pro iniectione Kabi Romania Apă pentru preparate injectabile Kabi, solvent pentru uz parenteral Slovakia Water for Injection Kabi Slovenia Voda za injekcije Fresenius Kabi vehikel za parenteralno uporabo Spain Agua para inyección Meinsol, disolvente para uso parenteral This leaflet was last approved in 03/2015 The following information is intended for medical or healthcare professionals only: Handling and Preparation Use only if the solution is clear, without visible particles and if the container is undamaged. Water for Injections should not be infused alone. The infusion should be made isotonic prior to parenteral administration. Solutions containing additives should be used immediately and not stored. Discard after single use. Discard any unused portion. What contains The only active ingredient is sterile water for injections. Each presentation contains 100% sterile water for injections. What looks like and contents of the pack is a clear solution, free from visible particles and it is presented as the following formats: Package with 20 ampoules containing 5 ml Package with 50 ampoules containing 5 ml Package with 20 ampoules containing 10 ml Package with 50 ampoules containing 10 ml Package with 20 ampoules containing 20 ml Package with 1 bottle containing 500 ml Package with 10 bottles containing 500 ml Package with 1 bottle containing 1000 ml Package with 10 bottles containing 1000 ml Not all pack sizes may be marketed Marketing Authorisation Holder and Manufacturer: Marketing Authorisation Holder Fresenius Kabi Limited, Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT United Kingdom V001/VS (BP9) In-use shelf-life: Additives Chemical and physical stability of any additive at the ph of Water for Injections (4.5 to 7.0) in the container should be established prior to use. From a microbiological point of view, the diluted product should be used immediately, unless reconstitution has taken place in controlled and validated aseptic conditions. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user. Incompatibilities of additive medications As with all parenteral solutions, before adding medications, compatibility of these additives with the solution must be assessed. The Instructions for Use of the medicinal product to be added must be consulted. Before adding a medicinal product, verify it is soluble and stable in water at the ph of Water for Injections (4.5 to 7.0)

(Irlanda) BP9 Colour: Black Size: 148 x 210 mm Size folding: 50 x 210 mm Fonts size: 12/6,5 pt 13.5.2015 Correction: 1 Version: 00